Pfizer Pharmaceuticals Inc.
Records under this name other than patents Pfizer Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Pfizer Pharmaceuticals Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,710,054 | Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents Formerly held Term ended Term ended Oct 15, 2021 · High confidence | Term ended | Term ended Oct 15, 2021 | High confidence |
| US 6,327,132 | Spark resistant structure, in particular for aircraft Formerly held Term ended Term ended Oct 8, 2019 · From the USPTO record | Term ended | Term ended Oct 8, 2019 | From the USPTO record |
| US 6,180,647 | Substituted benzolactam compounds as substance P antagonists Formerly held Lapsed on the fee record Ended Jan 30, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2013 | From the USPTO record |
| US 6,423,725 | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists Formerly held Lapsed on the fee record Ended Jul 23, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2010 | From the USPTO record |
| US 6,417,202 | Pyridylpyrrole compounds useful as interleukin-and TNF antagonists Lapsed on the fee record Ended Jul 9, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2010 | From the USPTO record |
| US 6,340,681 | 2-benzimidazolylamine compounds as ORL-1-receptor agonists Lapsed on the fee record Ended Jan 22, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2010 | From the USPTO record |
| US 6,979,690 | Oxo or Oxy-Pyridine Compounds as 5-HT4 Receptor Modulators Formerly held Lapsed on the fee record Ended Dec 27, 2009 · High confidence | Lapsed on the fee record | Ended Dec 27, 2009 | High confidence |
| US 6,310,079 | Benzimidazole cyclooxygenase-2 inhibitors Formerly held Lapsed on the fee record Ended Oct 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2009 | From the USPTO record |
| US 6,303,628 | Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents Formerly held Lapsed on the fee record Ended Oct 16, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2009 | From the USPTO record |
| US 6,300,363 | Indole compounds as COX-2 inhibitors Formerly held Lapsed on the fee record Ended Oct 9, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2009 | From the USPTO record |